引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 60次   下载 27 本文二维码信息
码上扫一扫!
PROTACs在肿瘤治疗领域的研究与应用
韩苏夏,孙潇,蔡梦娇
0
(西安交通大学第一附属医院肿瘤放疗科)
摘要:
【摘要】 蛋白水解靶向嵌合分子(protein proteolysistargeting chimeras,PROTACs)是一种可以直接降解靶蛋白的双功能嵌合体。PROTACs通过中间连接链将靶蛋白与E3泛素连接酶结合的配体连接起来,继而泛素化修饰靶蛋白,从而使其进入蛋白酶体途径降解。根据PROTACs的作用机理,可以设计合成靶向降解调控肿瘤发生发展相关蛋白的PROTAC分子,从而达到治疗肿瘤的效果。目前,多个靶向肿瘤相关蛋白(BET蛋白、TBK1、CDK4/6以及AR、ER等)的PROTAC分子已在体外和体内实验中表现出良好的作用效果,有望研究开发成为肿瘤靶向药物。本文将对PROTACs的发展及其在肿瘤治疗领域的应用进行述评。
关键词:  蛋白水解靶向嵌合分子  靶向药物  肿瘤治疗  泛素 蛋白酶体系统
DOI:
基金项目:陕西省创新人才推进计划重点科技创新团队
Research and application of PROTACs in the field of cancer therapy
HAN Suxia,SUN Xiao,CAI Mengjiao
(Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University)
Abstract:
【Abstract】Protein proteolysistargeting chimeras (PROTACs) is a bifunctional chimera that can directly degrade target molecules. PROTACs linked ligands that bind to target molecules and E3 ubiquitin ligase via an intermediate linker, and then ubiquitinated to modify and degrade target molecules through proteasome. Due to the mechanism of action of PROTACs, they can be used to design and synthesize PROTACs that regulate proteins related to tumor development, to achieve the effect of tumor treatment. Currently, PROTAC molecules targeting multiple cancerrelated proteins (BET protein, TBK1, cdk4/6, AR and ER, etc.) have been shown to have good effects in vitro and in vivo experiments, and are expected to be a means for the development of clinical tumor targeted drugs. The development of PROTACs and its application in tumor therapy will be described in detail.
Key words:  Protein proteolysis targeting chimeras  Targeted drug  Tumor therapy  Ubiquitin proteasome system

用微信扫一扫

用微信扫一扫